Severe Dengue
9
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Therapeutics for Moderate and Severe Dengue
Severe Dengue in Critical Care at Villavicencio, Colombia.
Anakinra in Dengue With Hyperinflammation ( AnaDen )
Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)
The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever
Innovative Multidisciplinary Strategies for Combating Severe Dengue
Dengue Effectiveness Study in the Philippines
Dengue Serostatus Study in the Philippines
Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore